#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Primary myelofibrosis Atopic keratoconjunctivitis Uveal melanoma Human papilloma virus immunisation Burkitt's lymphoma Cerebellar ataxia Astrocytoma malignant Synovial sarcoma metastatic Immune-mediated renal disorder Ewing's sarcoma metastatic Loss of consciousness B precursor type acute leukaemia Factor IX deficiency Heart disease congenital Squamous cell carcinoma of head and neck More trials…

    Learn about Rare Diseases

    Leukoencephalopathy – Life with Disease Epidermolysis bullosa – Diagnostics Ewing’s sarcoma metastatic – Trials in Disease Small intestine leiomyosarcoma – Diagnostics Undifferentiated sarcoma – Life with Disease Castleman’s disease – Diagnostics Congenital hypotransferrinaemia – Treatment Congenital nephrogenic diabetes insipidus – Life with Disease Angiosarcoma non-metastatic Sarcoidosis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Gad20-209-Fsp-A1 L-Histidine Hydrochloride Phenylbutyrate Ag-946 Phosphate Colistimethate Sodium Osilodrostat Allopurinol Sodium Prs-344 Talquetamab Lonvoguran Ilofotase Alfa Bnt314 GS-4321 Dacarbazine Pivekimab Sunirine Sunvozertinib Mebendazole Ropivacaine Hydrochloride Pasireotide Diaspartate Lebrikizumab More therapies…

    Learn about Your Condition

    Urinary incontinence Colon cancer stage III Anaemia of chronic disease Poor quality sleep C3 glomerulopathy Obsessive-compulsive disorder Paraesthesia Toxic nodular goitre Chondropathy Colitis Friedreich's ataxia Arrhythmia supraventricular Tumour of ampulla of Vater Substance use disorder Retinitis pigmentosa More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Eye Diseases

  • Randomized Study of Intravitreal mk-8748 Compared with Aflibercept in Patients with Neovascular Age‑Related Macular Degeneration

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Aflibercept
    Estonia Germany Latvia Poland Spain

  • Safety and Efficacy of Sodium Phenylbutyrate Eye Drops in Children with Myopia

    Recruiting

    2 1
    Investigated Diseases:
    • Myopia
    Investigated Drugs:
    • Sodium Phenylbutyrate
    Ireland

  • AMG 732 in Patients With Thyroid Eye Disease Who Did Not Respond or Relapsed After Previous Treatment

    Recruiting

    2 1 1
    Investigated Diseases:
    • Endocrine ophthalmopathy
    Investigated Drugs:
    • AMG 732
    France Greece Italy Poland Spain

  • Cenegermin Eye Drops for Persistent Corneal Epithelial Defect in Patients with Persistent Corneal Epithelial Defect

    Recruiting

    3 1 1
    Investigated Diseases:
    • Persistent corneal epithelial defect
    Investigated Drugs:
    • Cenegermin
    • Oxybuprocaine Hydrochloride
    • Tetracaine Hydrochloride
    Czechia France Germany Hungary Italy The Netherlands +2

  • FWY003 in Geographic Atrophy Secondary to Age-Related Macular Degeneration in Patients

    Recruiting

    2 1
    Investigated Diseases:
    • Dry age-related macular degeneration
    Bulgaria Czechia France Germany Hungary Italy +3

  • A study to evaluate the safety and tolerability of tinlarebant in patients with Stargardt disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Stargardt’s disease
    Investigated Drugs:
    • Tinlarebant
    Belgium France The Netherlands
1 2 3 … 38
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!